What compounding means
Compounding means making a drug to order in a pharmacy or by a doctor.
It can serve a need that a ready-made drug cannot meet.
As of September 26, 2026, these made-to-order drugs have no Food and Drug Administration (FDA) approval. That agency does not check their quality, risks or benefits before sale.
For this drug, there is also a firm legal limit.
This drug has a separate legal limit
Tesamorelin is legally a biologic, according to the FDA record reviewed September 28, 2026.
Here, biologic names a legal category based on the length of the chain of chemical building blocks in this medicine.
Federal law does not allow pharmacies to sell their own made-to-order versions of medicines in this category, as of September 26, 2026.
A pharmacy-made tesamorelin copy is therefore not a lawful lower-cost option, as of September 2026.
Ask for the drug's full name. A claim that it is made just for you does not resolve that legal limit.
Codes and labels answer different questions
No generic or copycat form of tesamorelin is approved, as of September 28, 2026.
A number called the National Drug Code (NDC) lists a medicine in a government directory.
That code does not prove that the FDA approved the drug, according to its September 26, 2026 guidance.
The approved product names are tesamorelin (EGRIFTA SV and EGRIFTA WR), as of September 28, 2026.
Neither label describes a mix with another peptide, a substance made of a short chain of chemical building blocks.
Separate the name from the claim
A drug code, a pharmacy licence and approval for a drug are not the same check.
Source notes
- FDA explanation of compounding
This explains the limits of compounding, including biologics.
- FDA tesamorelin application
This records which legal category applies to tesamorelin.
- FDA drug-code directory guidance
This explains what a directory code can establish.